The global demand for Cardiac Biomarkers Market is presumed to reach the market size of nearly USD 67.58 BN by 2030 from USD 18.2 BN in 2022 with a CAGR of 17.82% under the study period 2023 - 2030.
Cardiac biomarkers are protein molecules released into the bloodstream due to cardiac injury or stress. These biomarkers could be used to detect cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome, among other cardiovascular illnesses (ACS). Cardiac biomarker testing enables doctors to assess a patient's likelihood of developing such conditions. Troponin, creatine kinase-muscle/brain (CK-MB), B-type natriuretic peptide (BNP), high-sensitivity C-reactive protein (hs-CRP), troponin I and T, myoglobin, ischemia modified albumin (IMA), and other cardiac biomarkers are commonly employed as an integrated diagnostic method for cardiovascular diseases (CVDs).
Market Dynamics
The market will likely be fueled by an increase in the senior population and patients suffering from heart attacks and chest discomfort due to changing lifestyles. The increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment, and research in which cardiac biomarkers are used are significant elements boosting the market growth. In addition, technological advancements in cardiac biomarkers and favourable government initiatives to raise awareness about cardiovascular diseases are the key factors driving the cardiac biomarkers market. Moreover, increased funding for cardiac biomarker research from both public and private institutions is likely to support market growth in the coming years. However, a lack of public awareness is projected to stifle industry expansion
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiac biomarkers. The growth and trends of cardiac biomarkers industry provide a holistic approach to this study.
Market Segmentation
This section of the cardiac biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Myocardial Muscle Creatine Kinase (Ck-Mb)
- Troponins (T And I)
- Myoglobin
- Brain Natriuretic Peptide (Bnps) Or Nt-Probnp
- Ischemia Modified Albumin (Ima)
- Others
By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
By Location of Testing
- Point Of Care Testing
- Laboratory Testing
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Cardiac Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Cardiac Biomarkers Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cardiac biomarkers market include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux, Randox laboratories, Beckman Coulter and Thermo Fisher Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
